FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

These pens handle notes and can transform them into digital images, record audio, and edit pre-existing notes. Like the Livescribe Symphony Smartpen, which does all of those useful things ...

The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart ... single-patient-use prefilled pen; the prefilled pen dials in ...

Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to Novo Nordisk’s Novolog) that helps control blood sugar spikes when taken five to 10 minutes before a meal.

There are quite a few stylus apps available on the Play Store. Let’s take a look at the best stylus apps and S Pen apps for Android. The Adobe family has excellent apps for using a stylus.

Management provided a revenue guidance range of $1.34 billion to $1.36 billion for 2025, with gross margins expected to exceed 67% for the full year. Operating margins are forecasted to expand to ...

The approval is for both a 3 milliliter single-patient-use prefilled pen and a 10 milliliter multiple-dose vial. Like Novolog, Merilog should be administered within five to 10 minutes before eating.

Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple ... Novo Nordisk announced a planned 75% reduction in the cost of NovoLog. Then a few days later, Sanofi followed suit ...

The approval includes both a 3 mL single-patient-use prefilled pen and a 10 mL multiple-dose vial ... Biosimilars in the FDA’s Center for Drug Evaluation and Research. Like Novolog, Merilog should be ...